Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.31 is 94% below its 5-year average of 5.05, near the low end of its 5-year range (0.00–19.12).
As of the fiscal period ended Wednesday, December 31, 2025. 63.54% below its 12-month average of 0.85.
Reported quarterly current ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 0.31.
CURRENT RATIO
0.31
CURRENT RATIO AVG TTM
0.85
CURRENT RATIO AVG 3Y
1.34
CURRENT RATIO AVG 5Y
5.05
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-63.54%
CURRENT VS 3Y AVG
-76.93%
CURRENT VS 5Y AVG
-93.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
-91.11%
vs the sector median at left
NeuroSense Therapeutics Ltd.
Market Cap
$6.98M
Current Ratio
0.31
TTM Avg
0.85
3Y Avg
1.34
5Y Avg
5.05
Market Cap
$7.24M
Current Ratio
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.31M
Current Ratio
1.37
TTM Avg
4.18
3Y Avg
4.61
5Y Avg
4.18
Market Cap
$6.55M
Current Ratio
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroSense Therapeutics Ltd. (NRSN) | $6.98M | 0.31 | 0.85 | 1.34 | 5.05 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | 1.81 | 4.14 | 10.76 | 11.50 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.20M | 0.18 | 0.90 | 2.08 | 1.78 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.24M | 45.95 | 58.73 | 40.89 | 40.89 |
| KALA BIO, Inc. (KALA)vs › | $7.28M | 6.88 | 3.46 | 4.15 | 4.60 |
| Aclarion, Inc. (ACON)vs › | $6.66M | 16.20 | 7.76 | 4.60 | 3.08 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 1.37 | 4.18 | 4.61 | 4.18 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.55M | 10.21 | 3.61 | 3.34 | 4.20 |
| Longeveron Inc. (LGVN)vs › | $7.43M | 2.63 | 4.46 | 3.65 | 4.69 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.49M | 2.61 | 3.40 | 4.86 | 5.09 |
Current Ratio
0.31
Quick Ratio
0.31
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 0.31 |
| 2025-09-30 | 0.31 |
| 2025-06-30 | 0.71 |
| 2025-03-31 | 0.71 |
| 2024-12-31 | 2.21 |
| 2024-09-30 | 0.21 |
| 2024-06-30 | 0.46 |
| 2024-03-31 | 0.26 |
| 2023-12-31 | 0.84 |
| 2023-09-30 | 1.82 |
| 2023-06-30 | 2.52 |
| 2023-03-31 | 2.80 |
| 2022-12-31 | 4.28 |
| 2022-09-30 | 10.96 |
| 2022-06-30 | 15.09 |
| 2022-03-31 | 11.42 |
| 2021-12-31 | 19.12 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 8.08 |
| 2021-03-31 | 17.48 |
| 2020-12-31 | 6.38 |
| 2020-09-30 | 6.38 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
